Glen Sunohara, current President and Representative Director of J-CAN KK, has joined COSMO as Board Director as of January 1, 2021.
Glen will advise COSMO on short and long-term business plans and also leverage his experiences as an expert in healthcare to counsel the company on service enhancement and internal capability development.
Glen Sunohara is currently the President and Representative Director of J-CAN KK, a private investing and consulting firm. Prior to this, he worked for Shire as the President and Representative Director of Shire Japan KK.
Glen also led the Japan and Asia Pacific Region for Shire and helped build the expansion strategies for China, Taiwan and South Korea.
In these roles, he developed a passion to help patients with Rare Diseases lead a better life.
Glen began his career in Canada with Novartis as a Medical Liaison Specialist. He held a number of positions with Novartis. At the local level in Canada, these included Sales Representative, Regional Sales Manager and Brand Manager. At the Global level with Novartis in Basel, Switzerland, Glen was the Senior Global Brand Director for the company’s largest brand, Diovan and the Head of Global Cardiovascular Marketing.
In 2006, Glen moved to Japan with Novartis as the Head of Marketing.
He also held roles as Chief Marketing Officer with MSD Japan and Operating Officer with Boehringer Ingelheim.
Glen obtained his Ph.D. from the University of Toronto, examining the neurophysiology of ADHD and completed post-doctoral fellowships at the Hospital for Sick Children and Centre for Addiction and Mental Health in Toronto, examining the molecular neurogenetics of psychiatric conditions.